Abstract:Background: The incidence of glioma, a prevalent brain malignancy, is increasing, particularly among the elderly population. This study aimed to elucidate the clinical importance of epithelial-mesenchymal transition (EMT) in gliomas and its association with malignancy and prognosis. Background: The incidence of glioma, particularly among elderly individuals, is on the rise. The malignancy of glioma is determined not only by the oncogenic properties of tumor cells but also by the composition of the tumor microenvironment, which includes immune system macrophages. The prevalence of M2-type macrophages typically fosters tumor progression, yet the underlying mechanism remains elusive. Our study explored the clinical importance of epithelial-mesenchymal transition (EMT) in gliomas and its association with malignancy and prognosis. Methods: Our study used the gene set variation analysis (GSVA) algorithm to classify different levels of EMT activation based on the transcriptomic and multi-omics data. Machine learning (ML) and single-cell analysis were integrated into our model for comprehensive analysis. A predictive model was constructed and in vitro experiments were performed to validate our findings. Results: Our study classified 1,641 samples into two clusters based on EMT activation: the EMT-hot group and the EMT-cold group. The EMT-hot group had elevated copy number loss, tumor mutational burden (TMB), and a poorer survival rate. Conversely, the EMT-cold group showed a better survival rate, likely attributed to lower stromal and immune cell scores, as well as decreased expression of human leukocyte antigen-related genes. Driving genes were identified through weighted gene coexpression network analysis (WGCNA) and dimensionality reduction techniques. These genes were then utilized in the construction of a prognostic model using ML and protein-protein interaction (PPI) network analysis. Furthermore, the impact of the core genes identified through single-cell analysis on glioma prognosis was examined. Conclusion: Our research underscores the efficacy of our model in predicting glioma prognosis and elucidates the connection between the M2 macrophages and EMT. Additionally, core genes such as LY96, C1QB, LGALS1, CSPG5, S100A8, and CHGB were identified as pivotal for mediating the occurrence of EMT induced by M2 macrophages.

Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression

Origin, activation, and targeted therapy of glioma-associated macrophages

Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy

Association of M2 macrophages with EMT in glioma identified through combination of multi-omics and machine learning

The roles of glioma-associated macrophages/microglia and potential targets for anti-glioma therapy

Recruitment mechanisms and therapeutic implications of tumor-associated macrophages in the glioma microenvironment

Microglia and Brain Macrophages as Drivers of Glioma Progression

Rage Expression In Tumor-Associated Macrophages Promotes Angiogenesis In Glioma

Epidermal Growth Factor (Egf)-Enhanced Vascular Cell Adhesion Molecule-1 (Vcam-1) Expression Promotes Macrophage and Glioblastoma Cell Interaction and Tumor Cell Invasion

MiR-146a-5p deficiency in extracellular vesicles of glioma-associated macrophages promotes epithelial-mesenchymal transition through the NF-κB signaling pathway

Macrophages/Microglia in the Glioblastoma Tumor Microenvironment

The Role of Microglia in Glioblastoma

TAMI-31. MACROPHAGE M1 INVASION PREDICTS POOR PROGNOSIS OF GLIOMA AND REVEALS A STRATEGY FOR GLIOBLASTOMA THERAPY

The molecular feature of macrophages in tumor immune microenvironment of glioma patients

OS10.7.A Activation of the CCR8-ACP5 axis by human microglia/macrophage derived CCL18 promotes glioma growth

Hypoxia-induced TREM1 Promotes Mesenchymal-Like States of Glioma Stem Cells Via Alternatively Activating Tumor-Associated Macrophages

Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy

Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM

Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells Via TGF-β1 Signaling Pathway

Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma

Differences of macrophages in the tumor microenvironment as an underlying key factor in glioma patients